CervoMed Inc. (CRVO)
NASDAQ·Healthcare·Biotechnology
$3.80
-0.52%
Mkt Cap $42.01M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$22.50
Range $20.00 – $25.00
Implied Upside
+492.1%
Consensus $22.50 vs current $3.80
NASDAQ·Healthcare·Biotechnology
$3.80
-0.52%
Mkt Cap $42.01M
No recent rating data.
Price Target (6 analysts)
$22.50
Range $20.00 – $25.00
+492.1%
Consensus $22.50 vs current $3.80